tg-1701: monotherapy & combination with u2 for cll and lymphoma
Published 3 years ago • 60 plays • Length 3:33Download video MP4
Download video MP3
Similar videos
-
1:36
re-evaluating the role of radiation therapy in lymphoma & exploring combinations with immunotherapy
-
1:43
gilteritinib monotherapy vs combination therapy in r/r flt3-mutated aml
-
2:33
updates from a phase i clinical trial examining ublituximab in combination with tgr-1202
-
1:37
eo2463: a vaccine as a monotherapy or in combination with standard chemotherapy in nhl
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
1:22:04
tecnis eyhance webinar - beyond disruptive iol technology in monofocal cataract surgery - jnj
-
21:38
drawing the line: the rationale behind blood tube collection order
-
1:15
the role of btk inhibitors in the frontline treatment of mcl
-
1:17
globryte: investigating glofitamab monotherapy in patients with r/r mcl
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
3:04
monumental-1 update: talquetamab in r/r multiple myeloma
-
1:05
the prognostic and potentially therapeutic value of liquid biopsy in multiple myeloma
-
2:19
session highlights: autosct in t-cell lymphoma, classification updates and fertility preservation
-
1:09
cll treatment: discussing new data from the last 3 years
-
3:48
impressive data: zanubrutinib for waldenström’s macroglobulinemia
-
4:26
transcend-cll-004: lisocabtagene maraleucel in cll
-
9:52
myeloma highlights from soho 2023: updates with the use of novel targeted immunotherapies
-
1:08
evaluating ro7443904 in combination with glofitamab in patients with r/r nhl
-
1:02
maintenance therapy following treatment for amyloidosis
-
3:03
the evolution of treatment patterns and prognostic biomarkers in latin american cll patients
-
1:25
car-t in mm: karmma, cartitude-1 and evolve